Variantyx is a company headquartered in Israel. Brouky records 3 investors associated with the company.
Variantyx is a molecular diagnostics company that provides advanced genetic testing services, including whole genome, exome, and targeted analyses for rare genetic disorders, reproductive genetics, and precision oncology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.